STRESS NEUROPEPTIDES, DEPRESSION AND AGING
压力神经肽、抑郁和衰老
基本信息
- 批准号:6165120
- 负责人:
- 金额:$ 14.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-03-15 至 2003-02-28
- 项目状态:已结题
- 来源:
- 关键词:age difference aging amygdala corticosteroid receptors corticotropin releasing factor depression hypothalamus immature animal immunocytochemistry in situ hybridization interleukin 1 laboratory mouse laboratory rat mature animal neuropeptides physiologic stressor pituitary gland psychological stressor psychoneuroimmunology vasopressins
项目摘要
DESCRIPTION (Adapted from the Applicant's Abstract): Very little is known
about the molecular impact of immune and psychological stresses on the brain
in the elderly and even less is known about the role of their in the
pathogenesis of late life depression. Were this information known, the
potential applications toward improving the diagnoses and treatment of late
depression would be profound. There are, however, very few investigators
who are able to integrate molecular and clinical approaches with studies
involving elderly human populations. The research and educational
components of this K01 application will provide the necessary training for
the applicant to become such an investigator; this will involve close
contact with basic research and clinical mentors. The research plan is
basic science oriented and is based on the premise that stress neuropeptide
systems in the hypothalamus and amygdala are overactivated with aging.
Peptidergic overactivation is thought to reflect an overall decrease in
functional CNS reserve and thus plays a role in the pathogenesis of late
life depression. The hypotheses to be tested include: 1) Interleukin-1
administration to aged rats leads to a greater activation in hypothalamic
neuropeptide stress systems; 2) this is associated with decreases in
hippocampal corticosteroid receptors; 3) Restraint stress in aged rats leads
to a greater activation in amygdalar CRF systems; and, 4) this is associated
with overactivation of amygdalar phospho CREB. To test these hypotheses,
the following specific measures will be made in old age rats and compared
with rats of middle age and young adulthood: CRF and vasopressin gene and
peptide expression will be measured in the hypothalamus and pituitary
following central interleukin-1 (IL1) challenge. Hippocampal corticosteroid
binding will also be measured following central IL1. An additional set of
animals will be administered restraint stress; behavioral and molecular
measurements of amygdalar CRF systems will be made along with amygdalar
phosphoCERB levels. The development of mouse models will also be initiated
given that this species is amenable to transgenic manipulation. While
carrying out the basic research, the clinical mentors will oversee the
research program and also provide the applicant with tutorials in clinical
psychoneuroimmunology and late life depression. In addition, they will
provide the applicant with guidance, to apply the molecular findings of the
research to human populations. Completion of the 5-year program aims to
make the applicant an independent investigator who can integrate molecular
neuroendocrinology physiology research with clinical geropsychiatry
research.
描述(改编自申请人的摘要):知之甚少
免疫和心理压力对大脑的分子影响
在老年人中,更少有人知道他们在老年人中的作用。
晚年抑郁症的发病机制。 如果知道这些信息,
潜在的应用,以改善诊断和治疗晚期
抑郁症会很严重 然而,很少有调查人员
他们能够将分子和临床方法与研究相结合
涉及老年人口。 研究和教育
本K 01应用程序的组件将提供必要的培训,
申请人成为这样的调查员;这将涉及密切
与基础研究和临床导师的联系。 研究计划是
基础科学为导向,是以应激神经肽为前提的
下丘脑和杏仁核中的神经系统随着年龄的增长而过度活跃。
肽能过度活化被认为反映了细胞凋亡的总体减少。
功能性CNS储备,因此在晚期
生活抑郁症 待检验的假设包括:1)白细胞介素-1
对老年大鼠给药导致下丘脑中更大的激活
神经肽应激系统; 2)这与减少
海马皮质类固醇受体; 3)老年大鼠的束缚应激导致
杏仁核CRF系统的激活程度更高; 4)这与
杏仁核磷酸化CREB过度激活 为了验证这些假设,
对老年大鼠进行以下具体措施并进行比较
中年和青年大鼠:CRF和加压素基因,
将在下丘脑和垂体中测量肽表达
中枢白细胞介素-1(IL-1)激发后。 海马皮质类固醇
结合也将在中心IL 1后测量。 附加的一组
动物将被给予束缚应激;行为和分子
将沿着杏仁核CRF系统的测量,
磷酸化CERB水平。 小鼠模型的开发也将启动
因为这个物种可以进行转基因操作。 而
进行基础研究,临床导师将监督
研究计划,并为申请人提供临床指导
心理神经免疫学和晚年抑郁症 此外,他们将
为申请人提供指导,以应用
对人类的研究。 完成5年计划的目的是
使申请人成为一名独立的研究者,
神经内分泌生理学研究与临床老年精神病学
research.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN W. KASCKOW其他文献
JOHN W. KASCKOW的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN W. KASCKOW', 18)}}的其他基金
Improving Outcomes in Suicidal Veterans with Schizophrenia
改善患有精神分裂症的自杀退伍军人的治疗结果
- 批准号:
8203041 - 财政年份:2012
- 资助金额:
$ 14.92万 - 项目类别:
Antidepressant Augmentation of Late Life Schizophrenia
抗抑郁药可增强晚年精神分裂症的疗效
- 批准号:
6936454 - 财政年份:2001
- 资助金额:
$ 14.92万 - 项目类别:
Antidepressant Augmentation of Late Life Schizophrenia
抗抑郁药可增强晚年精神分裂症的疗效
- 批准号:
6793739 - 财政年份:2001
- 资助金额:
$ 14.92万 - 项目类别:
Antidepressant Augmentation of Late Life Schizophrenia
抗抑郁药可增强晚年精神分裂症的疗效
- 批准号:
6654980 - 财政年份:2001
- 资助金额:
$ 14.92万 - 项目类别:
Antidepressant Augmentation of Late Life Schizophrenia
抗抑郁药可增强晚年精神分裂症的疗效
- 批准号:
7382983 - 财政年份:2001
- 资助金额:
$ 14.92万 - 项目类别:
Antidepressant Augmentation of Late Life Schizophrenia
抗抑郁药可增强晚年精神分裂症的疗效
- 批准号:
6528976 - 财政年份:2001
- 资助金额:
$ 14.92万 - 项目类别:
Antidepressant Augmentation of Late Life Schizophrenia
抗抑郁药可增强晚年精神分裂症的疗效
- 批准号:
6360376 - 财政年份:2001
- 资助金额:
$ 14.92万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 14.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 14.92万 - 项目类别:
Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 14.92万 - 项目类别:
Collaborative R&D
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 14.92万 - 项目类别:
Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 14.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 14.92万 - 项目类别:
Studentship
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 14.92万 - 项目类别:
Fellowship Award
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 14.92万 - 项目类别:
Standard Grant
McGill-MOBILHUB: Mobilization Hub for Knowledge, Education, and Artificial Intelligence/Deep Learning on Brain Health and Cognitive Impairment in Aging.
McGill-MOBILHUB:脑健康和衰老认知障碍的知识、教育和人工智能/深度学习动员中心。
- 批准号:
498278 - 财政年份:2024
- 资助金额:
$ 14.92万 - 项目类别:
Operating Grants
Welfare Enhancing Fiscal and Monetary Policies for Aging Societies
促进老龄化社会福利的财政和货币政策
- 批准号:
24K04938 - 财政年份:2024
- 资助金额:
$ 14.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)